IHM
CLDX icon

Iguana Healthcare Management’s Celldex Therapeutics CLDX Stock Holding History

Iguana Healthcare Management’s Portfolio CLDX Stock Details CLDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-5,000
Closed -$972K – 64
2014
Q3 		$972K Buy
+5,000
New +$1.09M 0.52% 49
2014
Q2 		– Sell
-3,333
Closed -$884K – 68
2014
Q1 		$884K Hold
3,333
– – 0.41% 61
2013
Q4 		$1.31M Buy
+3,333
New +$1.28M 0.75% 43

Other funds holding CLDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Iguana Healthcare Management's CLDX Position: Q3 2015 in Review

Iguana Healthcare Management sold out of Celldex Therapeutics (CLDX) in Q3 2015, closing a stake of 5,000 shares — an estimated $1.89M sold.

Iguana Healthcare Management first reported a position in CLDX in Q4 2013 and held it in 7 quarters. The position peaked at $4.84M in Q4 2013. 162 funds tracked by Wall St. Rank hold CLDX as of Q3 2015.

  • Iguana Healthcare Management reported no remaining Celldex Therapeutics position as of Q3 2015 after selling out during the quarter.
  • Iguana Healthcare Management sold 5,000 Celldex Therapeutics shares in Q3 2015, an estimated $1.89M.
  • Iguana Healthcare Management first reported a position in Celldex Therapeutics in Q4 2013 and held it in 7 quarters.
  • Iguana Healthcare Management's Celldex Therapeutics position peaked at $4.84M in Q4 2013.
  • 162 funds tracked by Wall St. Rank held Celldex Therapeutics as of Q3 2015.

Based on Iguana Healthcare Management's 13F filing for Q3 2015, filed 16 Nov 2015.